세계의 금 나노입자 시장 보고서 : 유형, 용도, 최종 이용 산업, 지역별(2025-2033년)

The global gold nanoparticles market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.6 Billion by 2033, exhibiting a growth rate (CAGR) of 10.1% during 2025-2033. Numerous advancements in the medical industry, along with the introduction of injectable plant plastids, are primarily stimulating the market growth.

Gold nanoparticles, represented as AuNPs, are gold particles with a diameter of 1 to 100 nanometers (nm). They are majorly used in biomedical and biotechnological sciences for their large surface area and bio-inertness. They also have high electron conductivity, stability and solubility. These particles are manufactured in the form of nanospheres, nanocages, nanorods, nanoshells, nanocubes and nanoclusters and find extensive application in targeted drug administration and as agents in biomolecules delivery. Gold nanoparticles are also utilized as optical imaging probes for detection of biomarkers of various diseases and in imaging procedures such as positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound scans.

Gold Nanoparticles Market Trends:

The growing medical industry, along with the growing demand for nanotechnological medical products, represent as the key factors driving the growth of the market. Gold nanoparticles are increasingly being used in the medical industry, especially in the dental sector, for various purposes including target imaging for cancer therapy and dental filling. Furthermore, the flourishing electronics industry is also significantly contributing to the market growth as these nanoparticles are extensively utilized to produce inks used in storage devices, hard disks and microchips. They are also used in the manufacturing of thin-film transistors and photo-sensors. Additionally, the food and beverage industry widely utilize colorimetric sensors that are manufactured using these particles. These sensors assist in detecting the freshness and consumability of food products. Various technological advancements, such as the development of injectable plant plastids to enhance biosynthesis and extensive research and development (R&D), are also driving the market further.

Key Market Segmentation:

Breakup by Type:

• Water Soluble
• Oil Soluble
• Others

Breakup by Application:

• Imaging
• Targeted Drug Delivery
• Sensors
• In Vitro Diagnostics
• Probes
• Catalysis
• Others

Breakup by End-Use Industry:

• Electronics
• Healthcare
• Chemicals
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, BBI Solutions, Cline Scientific, Cytodiagnostics, Expedeon, Goldsol, Meliorum Technologies, Merck Group, Metalor Technologies International , Nanocomposix, NanoHybrids, Nanopartz, Sigma-Aldrich, Solaris Nanosciences Corporation, Tanaka Kikinzoku, etc.

Key Questions Answered in This Report:

• How has the global gold nanoparticles market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global gold nanoparticles market?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end-use industry?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global gold nanoparticles market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Gold Nanoparticles Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Water Soluble
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Oil Soluble
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Imaging
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Targeted Drug Delivery
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Sensors
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 In Vitro Diagnostics
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Probes
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Catalysis
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by End-Use Industry

• 8.1 Electronics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Healthcare
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Chemicals
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Agilent Technologies
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 BBI Solutions
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Cline Scientific
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Cytodiagnostics
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Expedeon
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Goldsol
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Meliorum Technologies
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Merck Group
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Metalor Technologies International
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Nanocomposix
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 NanoHybrids
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Nanopartz
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Sigma-Aldrich
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
  • 14.3.14 Solaris Nanosciences Corporation
    • 14.3.14.1 Company Overview
    • 14.3.14.2 Product Portfolio
  • 14.3.15 Tanaka Kikinzoku
    • 14.3.15.1 Company Overview
    • 14.3.15.2 Product Portfolio